Although our data indicates that CD44 does not preferentially select for tissue-specific metastasis in vivo, CD44 knockdown on stem-cell-like CD44+/CD24−/low MDA-MB-231 cells did significantly decrease tumor burden and reduced the incidence of metastatic lesions in the hind limbs of animals. Here, CD44 is linked to neoplasm.